IBDEI1V9 ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,31235,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31235,1,3,0)
 ;;=3^Dementia w/ Behavioral Disturbances,Unspec
 ;;^UTILITY(U,$J,358.3,31235,1,4,0)
 ;;=4^F03.91
 ;;^UTILITY(U,$J,358.3,31235,2)
 ;;=^5133350
 ;;^UTILITY(U,$J,358.3,31236,0)
 ;;=G31.83^^135^1392^14
 ;;^UTILITY(U,$J,358.3,31236,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31236,1,3,0)
 ;;=3^Dementia w/ Lewy Bodies
 ;;^UTILITY(U,$J,358.3,31236,1,4,0)
 ;;=4^G31.83
 ;;^UTILITY(U,$J,358.3,31236,2)
 ;;=^329888
 ;;^UTILITY(U,$J,358.3,31237,0)
 ;;=F01.51^^135^1392^30
 ;;^UTILITY(U,$J,358.3,31237,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31237,1,3,0)
 ;;=3^Vascular Dementia w/ Behavioral Disturbances
 ;;^UTILITY(U,$J,358.3,31237,1,4,0)
 ;;=4^F01.51
 ;;^UTILITY(U,$J,358.3,31237,2)
 ;;=^5003047
 ;;^UTILITY(U,$J,358.3,31238,0)
 ;;=F01.50^^135^1392^31
 ;;^UTILITY(U,$J,358.3,31238,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31238,1,3,0)
 ;;=3^Vascular Dementia w/o Behavioral Disturbances
 ;;^UTILITY(U,$J,358.3,31238,1,4,0)
 ;;=4^F01.50
 ;;^UTILITY(U,$J,358.3,31238,2)
 ;;=^5003046
 ;;^UTILITY(U,$J,358.3,31239,0)
 ;;=A81.9^^135^1392^6
 ;;^UTILITY(U,$J,358.3,31239,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31239,1,3,0)
 ;;=3^Atypical Virus Infection of CNS,Unspec
 ;;^UTILITY(U,$J,358.3,31239,1,4,0)
 ;;=4^A81.9
 ;;^UTILITY(U,$J,358.3,31239,2)
 ;;=^5000414
 ;;^UTILITY(U,$J,358.3,31240,0)
 ;;=A81.09^^135^1392^8
 ;;^UTILITY(U,$J,358.3,31240,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31240,1,3,0)
 ;;=3^Creutzfeldt-Jakob Disease NEC
 ;;^UTILITY(U,$J,358.3,31240,1,4,0)
 ;;=4^A81.09
 ;;^UTILITY(U,$J,358.3,31240,2)
 ;;=^5000410
 ;;^UTILITY(U,$J,358.3,31241,0)
 ;;=A81.00^^135^1392^9
 ;;^UTILITY(U,$J,358.3,31241,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31241,1,3,0)
 ;;=3^Creutzfeldt-Jakob Disease,Unspec
 ;;^UTILITY(U,$J,358.3,31241,1,4,0)
 ;;=4^A81.00
 ;;^UTILITY(U,$J,358.3,31241,2)
 ;;=^5000409
 ;;^UTILITY(U,$J,358.3,31242,0)
 ;;=A81.01^^135^1392^10
 ;;^UTILITY(U,$J,358.3,31242,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31242,1,3,0)
 ;;=3^Creutzfeldt-Jakob Disease,Variant
 ;;^UTILITY(U,$J,358.3,31242,1,4,0)
 ;;=4^A81.01
 ;;^UTILITY(U,$J,358.3,31242,2)
 ;;=^336701
 ;;^UTILITY(U,$J,358.3,31243,0)
 ;;=A81.89^^135^1392^7
 ;;^UTILITY(U,$J,358.3,31243,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31243,1,3,0)
 ;;=3^Atypical Virus Infections of CNS NEC
 ;;^UTILITY(U,$J,358.3,31243,1,4,0)
 ;;=4^A81.89
 ;;^UTILITY(U,$J,358.3,31243,2)
 ;;=^5000413
 ;;^UTILITY(U,$J,358.3,31244,0)
 ;;=A81.2^^135^1392^27
 ;;^UTILITY(U,$J,358.3,31244,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31244,1,3,0)
 ;;=3^Progressive Multifocal Leukoencephalopathy
 ;;^UTILITY(U,$J,358.3,31244,1,4,0)
 ;;=4^A81.2
 ;;^UTILITY(U,$J,358.3,31244,2)
 ;;=^5000411
 ;;^UTILITY(U,$J,358.3,31245,0)
 ;;=B20.^^135^1392^17
 ;;^UTILITY(U,$J,358.3,31245,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31245,1,3,0)
 ;;=3^HIV Disease w/ Dementia w/ Behavioral Disturbances
 ;;^UTILITY(U,$J,358.3,31245,1,4,0)
 ;;=4^B20.
 ;;^UTILITY(U,$J,358.3,31245,2)
 ;;=^5000555^F02.81
 ;;^UTILITY(U,$J,358.3,31246,0)
 ;;=B20.^^135^1392^18
 ;;^UTILITY(U,$J,358.3,31246,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31246,1,3,0)
 ;;=3^HIV Disease w/ Dementia w/o Behavioral Disturbances
 ;;^UTILITY(U,$J,358.3,31246,1,4,0)
 ;;=4^B20.
 ;;^UTILITY(U,$J,358.3,31246,2)
 ;;=^5000555^F02.80
 ;;^UTILITY(U,$J,358.3,31247,0)
 ;;=F10.27^^135^1392^1
 ;;^UTILITY(U,$J,358.3,31247,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31247,1,3,0)
 ;;=3^Alcohol Dependence w/ Alcohol-Induced Persisting Dementia
 ;;^UTILITY(U,$J,358.3,31247,1,4,0)
 ;;=4^F10.27
